Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04844762 · ClinicalTrials.gov registry record · NA
Addiction and Behavior Related to Menthol Cigarette Substitutes
A NA study of Smoking (Tobacco) Addiction, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT04844762: Completed NA study of Smoking (Tobacco) Addiction, sponsored by Ohio State University Comprehensive Cancer Center.
NCT04844762 is a NA study of Smoking (Tobacco) Addiction that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 120 participants, below the 375-participant average among 6 other Smoking (Tobacco) Addiction trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04844762, a NA study of Smoking (Tobacco) Addiction, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the proposed study is to examine the abuse liability and substitutability of plausible menthol cigarette alternatives currently on the market, including menthol filtered little cigars (mFLC), menthol roll-your-own (mRYO) pipe tobacco and cigarette tubes, and non-menthol cigarettes (nmC). In addition, the study will elucidate real-time mechanisms including product characteristics and perceived effects associated with greater substitution.
Primary Outcome
Average puff duration for each participant, in seconds.
Conditions Studied
Interventions
- BEHAVIORAL Menthol cigarettes substitutes
- BEHAVIORAL Usual brand menthol cigarettes and substitutes
- BEHAVIORAL Menthol cigarettes substitutes and menthol cigarettes
Study Locations (1)
Ohio
- The Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2019-12-16 |
| Est. Completion | 2021-08-09 |
| Phase | NA |
What the finished NCT04844762 record still lists
NCT04844762 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 375-participant average among 6 other Smoking (Tobacco) Addiction trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Smoking (Tobacco) Addiction appearing as the primary indexed condition, and to 3 interventions - of which Menthol cigarettes substitutes is the first listed.
NCT04844762 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04844762 about?
NCT04844762 is a clinical study titled "Addiction and Behavior Related to Menthol Cigarette Substitutes". The goal of the proposed study is to examine the abuse liability and substitutability of plausible menthol cigarette alternatives currently on the market, including menthol filtered little cigars (mFLC), menthol roll-your-own (mRYO) pipe tobacco and cigarette tubes, and non-menthol cigarettes (nmC)....
What is the current status of trial NCT04844762?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2019-12-16. Estimated completion is 2021-08-09.
What conditions does trial NCT04844762 study?
This clinical trial studies the following conditions: Smoking (Tobacco) Addiction.
What interventions are being tested in trial NCT04844762?
The interventions under investigation include: Menthol cigarettes substitutes (BEHAVIORAL), Usual brand menthol cigarettes and substitutes (BEHAVIORAL), Menthol cigarettes substitutes and menthol cigarettes (BEHAVIORAL).
Who is sponsoring clinical trial NCT04844762?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04844762 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking (Tobacco) Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
RECRUITING · NA
-
Helping Poor Smokers Quit
COMPLETED · NA
-
Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis
RECRUITING · Phase 2
-
Addiction Potential of Very Low Nicotine Filtered Little Cigars
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI